Gram Research analysis shows that buprenorphine successfully treated 7-hydroxymitragynine (7-OH) dependence in 8 out of 9 patients (88.9%) with no serious side effects or withdrawal complications. A 2026 retrospective case series found that patients starting buprenorphine for purified 7-OH use reported symptom improvement within six weeks, suggesting this established opioid addiction medication can be safely adapted for this emerging substance use disorder.
A new study from 2026 looked at how a medication called buprenorphine helps people who have become dependent on purified 7-hydroxymitragynine (7-OH), a concentrated extract from kratom. Kratom is a plant supplement that some people use for pain relief and mood support, but the purified version can be much stronger and more addictive. Researchers reviewed 9 patients who received buprenorphine treatment at a telehealth addiction clinic. The treatment worked well for almost 9 out of 10 patients, with no serious side effects. Most patients felt better within six weeks. This research suggests buprenorphine could be a helpful tool for doctors treating people struggling with 7-OH dependence.
Key Statistics
A 2026 retrospective case series of 9 patients found that buprenorphine successfully treated 7-hydroxymitragynine dependence in 88.9% of cases, with no precipitated withdrawal or serious adverse events reported.
According to research reviewed by Gram, 8 out of 9 patients (88.9%) receiving buprenorphine for purified 7-OH dependence reported symptom improvement at a median six-week follow-up in a 2026 case series.
A 2026 study of 9 patients showed that both low-dose and standard-dose buprenorphine initiation strategies were effective for 7-hydroxymitragynine dependence, with no serious safety concerns identified.
The Quick Take
- What they studied: Whether buprenorphine (a medication used to treat opioid addiction) could safely help people who became dependent on purified 7-OH, a concentrated extract from kratom.
- Who participated: Nine patients (mostly men, average age 33.5 years) who were using purified 7-OH products and received treatment at a telehealth addiction clinic between April and October 2025.
- Key finding: Buprenorphine worked well for 8 out of 9 patients (88.9% success rate) with no serious side effects or withdrawal problems. Most patients reported feeling better within six weeks.
- What it means for you: If you or someone you know is struggling with 7-OH dependence, buprenorphine may be a safe and effective treatment option. However, this is a small study, so talk to a doctor about whether it’s right for your situation.
The Research Details
Researchers looked back at medical records from 9 patients who received buprenorphine treatment for 7-OH dependence at a telehealth addiction clinic between April and October 2025. This type of study is called a ‘retrospective case series,’ which means doctors reviewed what happened after treatment was already completed, rather than following patients forward in time. The researchers tracked how patients started the medication, what doses they received, and how they responded over time. Six patients started with low doses, while three started with standard doses. Doctors monitored patients for withdrawal symptoms, side effects, and overall improvement.
This research matters because 7-OH is a newer, concentrated form of kratom that’s becoming more popular but also more problematic. Unlike regular kratom, purified 7-OH can be much stronger and more addictive because it bypasses the body’s normal breakdown processes. There are currently no official treatment guidelines for 7-OH dependence, so doctors need real-world examples of what works. This study provides practical information about how buprenorphine—a well-established addiction treatment—can be adapted for this emerging problem.
This is a small study (only 9 patients) from one telehealth clinic, so results may not apply to everyone. The study looked backward at existing medical records rather than following patients prospectively, which limits what we can conclude. However, the consistent positive results and lack of serious side effects are encouraging signs. The study was published in a peer-reviewed journal (Journal of Addiction Medicine), which means other experts reviewed it before publication. Readers should know this is early evidence that suggests buprenorphine is worth studying further, not definitive proof it’s the best treatment.
What the Results Show
Buprenorphine treatment was successful in 8 out of 9 patients (88.9% success rate). No patients experienced precipitated withdrawal—a dangerous condition where starting buprenorphine too quickly causes severe withdrawal symptoms. No serious adverse events were reported. The treatment approach was flexible: six patients started with low doses and three started with standard doses, and both approaches worked well. At the median follow-up point of six weeks, eight patients reported improvement in their symptoms, including reduced cravings, better mood, and less physical discomfort. The fact that the treatment was well-tolerated suggests buprenorphine can be safely adapted for 7-OH dependence, even though it wasn’t originally designed for this specific substance.
The study found that both low-dose and standard-dose initiation strategies were effective, suggesting doctors have flexibility in how they start patients on buprenorphine. This is important because it means treatment can be tailored to individual patient needs. The telehealth delivery model also proved feasible, suggesting that people struggling with 7-OH dependence can access treatment remotely, which may reduce barriers to care. The median six-week timeline for symptom improvement provides realistic expectations for patients considering this treatment.
This is one of the first studies specifically examining buprenorphine for 7-OH dependence. While buprenorphine has been used successfully for decades to treat opioid addiction, 7-OH is a newer substance with different properties. The high success rate (88.9%) is comparable to or better than buprenorphine’s effectiveness for traditional opioid dependence, which typically ranges from 70-90%. The lack of precipitated withdrawal is particularly notable because 7-OH’s opioid-like effects are stronger than regular kratom, making withdrawal management more challenging. This suggests buprenorphine’s mechanism may work well for 7-OH despite it being a different substance.
The study is small (only 9 patients), so results may not apply to larger, more diverse populations. All patients were treated at one telehealth clinic, which may have different practices than other treatment centers. The study only followed patients for a median of six weeks, so we don’t know about long-term outcomes or relapse rates. The study didn’t include a control group (patients not receiving buprenorphine), so we can’t be certain the improvement was due to the medication rather than other factors. The study focused on purified 7-OH products specifically, not regular kratom, so results may differ for people using whole kratom leaf. Finally, the study was retrospective, meaning doctors reviewed records after the fact rather than carefully monitoring patients during treatment.
The Bottom Line
Based on this early evidence, buprenorphine appears to be a reasonable treatment option for people struggling with 7-OH dependence. However, this should only be pursued under medical supervision. Talk to an addiction medicine specialist or your doctor about whether buprenorphine is appropriate for your situation. The evidence is moderate strength (small study, but consistent positive results), so consider this as one option among several possible approaches. Do not attempt to use buprenorphine without medical guidance.
This research is most relevant for people who are dependent on purified 7-OH products and seeking treatment. It’s also important for addiction medicine doctors, telehealth providers, and public health officials developing treatment guidelines for 7-OH dependence. People using regular kratom (not purified 7-OH) should know this study doesn’t directly apply to them. Healthcare providers should care about this because it suggests a practical approach to an emerging substance use problem.
Based on this study, most people can expect to see symptom improvement within six weeks of starting buprenorphine. However, individual timelines vary. Some people may feel better sooner, while others may take longer. Long-term success (staying off 7-OH) requires ongoing treatment and support, typically lasting months to years, similar to other opioid addiction treatments.
Frequently Asked Questions
Can buprenorphine treat kratom or 7-OH addiction?
Research shows buprenorphine successfully treated 7-OH dependence in 8 out of 9 patients (88.9%) with no serious side effects. However, this was a small 2026 study, so more research is needed. Talk to an addiction medicine doctor about whether it’s appropriate for your situation.
What is 7-hydroxymitragynine and why is it dangerous?
7-OH is a concentrated extract from kratom that’s much stronger than the whole plant. It acts like an opioid in the brain and can cause dependence more easily than regular kratom because it bypasses the body’s normal breakdown processes, delivering disproportionately strong effects.
How long does it take to feel better on buprenorphine for 7-OH?
A 2026 study found that most patients reported symptom improvement within six weeks of starting buprenorphine. However, individual timelines vary. Some people may feel better sooner, while others take longer. Long-term recovery typically requires months to years of treatment.
Is buprenorphine safe for treating 7-OH dependence?
A 2026 case series of 9 patients found buprenorphine was well-tolerated with no serious adverse events or precipitated withdrawal. However, this is a small study, so treatment should only be pursued under medical supervision with an addiction specialist monitoring your progress.
Can I get buprenorphine treatment for 7-OH through telehealth?
Yes, a 2026 study showed buprenorphine treatment for 7-OH dependence was successfully delivered through a telehealth addiction clinic. Remote treatment may increase access for people who have difficulty reaching in-person clinics, though you’ll still need medical supervision.
Want to Apply This Research?
- Track daily withdrawal symptoms on a scale of 1-10 (including cravings, anxiety, body aches, and mood). Log your buprenorphine dose and any side effects. Record energy level and sleep quality each morning. This creates a clear picture of how treatment is working over time.
- Set daily reminders to take buprenorphine at the same time each day. Use the app to log cravings when they happen and note what triggered them. Schedule weekly check-ins with your doctor through the app. Track non-medication coping strategies you use (exercise, meditation, calling a friend) to build a complete recovery toolkit.
- Create a weekly summary view showing your symptom scores, medication adherence, and mood trends. Set monthly goals (e.g., ‘reduce cravings by 20%’). Share reports with your healthcare provider during telehealth visits. Use the app to identify patterns—for example, if cravings spike at certain times or in certain situations—so you can develop targeted strategies.
This article summarizes research findings and is not medical advice. Buprenorphine is a prescription medication that should only be used under the supervision of a qualified healthcare provider. If you or someone you know is struggling with 7-OH or kratom dependence, consult with an addiction medicine specialist or your doctor before starting any treatment. This study involved only 9 patients and represents early evidence; individual results may vary. Do not start, stop, or change any medication without medical guidance. If you’re experiencing withdrawal symptoms or a medical emergency, seek immediate professional help.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.